History of HCC status post TACE/RFA of 3 hepatic lesions. ABDOMEN:LIVER, BILIARY TRACT: Cirrhotic liver morphology with a nodular contour, left hepatic lobe hypertrophy and fissural widening.Segment 5 ablation cavity measures 3.9 x 1.9 cm) (series 9/249). Adjacent to the anterolateral cranial aspect of this ablation cavity is a residual focus of arterial enhancement measuring 1.7 x 1.4 cm (series 9/35). This associated with restricted diffusion without definite washout.Segment 6 ablation cavity measures 2.8 x 1.0 cm (series 9/247). Adjacent to the medial cranial aspect of this ablation cavity is a 1.3 x 1.2 cm residual focus of arterial enhancement (series 9/30), increased in size from the prior where it measured 1.1 x 1.0 cm (series 10/44). This is associated with restricted diffusion without definite washout.Additional punctate subcentimeter enhancing focus in segment 8 (series 9/29) is unchanged, measuring 7 x 6 mm.Segment 3 ablation cavity measures 2.6 x 1.1 cm (series 9/242). SPLEEN: Splenomegaly measuring 18 cm in craniocaudal dimension. Numerous siderotic nodules.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: No significant abnormality noted.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
Post-ablation changes of the liver. There are residual arterially enhancing lesions adjacent to the segment 5 and segment 6 ablation cavities. The segment 6 enhancing focus demonstrates interval mild increase in size. Stable non-specific enhancing subcentimeter focus in segment 8.